Join our Community
Support ToI and remove all ads
Learn more
×

Dror Ben-Asher

RedHill's RHB-105 or Talicia drug for H. pylori. (Courtesy)
November 4, 2019, 3:12 pm
RedHill gets FDA nod for drug to eradicate gut infection
Israeli firm plans to start selling the pill in the US in first quarter 2020, targeting more than 2 million patients treated for H. pylori infection annually; shares surge
By Shoshanna Solomon
RedHill's RHB-105 or Talicia drug for H. pylori. (Courtesy)
December 3, 2018, 5:58 pm
Israel’s RedHill says drug shown effective in eradicating gut infection
Biotech firm’s Talicia drug was found in a late-stage study to vanquish H. pylori in 84% of patients; the bacteria can cause ulcers and gastric cancer
By Shoshanna Solomon
Illustrative. (Bet_Noire; iStock by Getty Images)
October 24, 2018, 11:59 am
RedHill gets added backwind for drug to treat Crohn’s disease
Israeli biopharmaceutical firm is also awaiting results of critical study on its drug to combat H. pylory, the bacteria that can cause peptic ulcer and gastric cancer
By Shoshanna Solomon
Illustrative photo of pharmaceutical pills. (Abed Rahim Khatib/Flash90)
June 14, 2017, 4:27 pm
Israel’s RedHill says gastroenteritis drug found safe in study
In Phase III GUARD study, Bekinda in 24 mg was found to be efficacious and well-tolerated, biotech firm says
By Shoshanna Solomon
The red hill seen from Kibbutz Givat Brenner that inspired the name of biotech company RedHill (Courtesy)
April 13, 2017, 12:29 pm
Kibbutz duo-turned-entrepreneurs on quest to whip gut bugs
Israeli biotech firm RedHill is conducting late-stage clinical trials to tackle Crohn’s disease and the ulcer-generating H. pylori bacteria
By Shoshanna Solomon
Load More
Sign in or Join The Times of Israel Community
Paying ToI Community members are invited to comment on articles
Please use the following structure: example@domain.com
Or Continue with
By joining you agree to the terms and conditions
Register to continue
Or Continue with
Log in to continue
Sign in or Join The Times of Israel Community
Only ToI Community members can comment below articles
Forgot your password? / Send me a login link
Or Continue with
check your email
Check your email
We sent an email to you at .
It has a link that will sign you in.
Join The Times of Israel Community
Commenting is available for paying members of The Times of Israel Community only. Please join our Community to comment and enjoy other Community benefits.
Please use the following structure: example@domain.com
Confirm Mail
Thank you! Now check your email
You are now a member of The Times of Israel Community! We sent you an email with a login link to . Once you're set up, you can start enjoying Community benefits and commenting.
Back to top
Never miss breaking news on Israel
Get notifications to stay updated
You're subscribed
image
Register for free
and continue reading
Registering allows you to manage your newsletters and alerts and helps us improve your experience. It takes just a few seconds.
Already registered? Enter your email to sign in.
Please use the following structure: example@domain.com
Or Continue with
By registering you agree to the terms and conditions. Once registered, you’ll receive our Daily Edition email for free.
Register to continue
Or Continue with
Log in to continue
Sign in or Register
I forgot my password / Send me a sign in link
Or Continue with
check your email
Check your email
We sent an email to you at .
It has a link that will sign you in.